5//SEC Filing
Nelson Christopher M. 5
Accession 0001493152-21-003965
CIK 0001310527other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:00 PM ET
Size
8.8 KB
Accession
0001493152-21-003965
Insider Transaction Report
Form 5
Nelson Christopher M.
DirectorCEO
Transactions
- Award
COMMON STOCK
2020-10-26$0.22/sh+423,609$93,194→ 696,041 total - Award
SERIES E-1 PREFERRED STOCK
2020-12-30+850→ 850,000 totalExercise: $0.00From: 2020-12-30→ COMMON STOCK (850,000 underlying)
Holdings
- 11,400
Options to buy Common Stock
Exercise: $0.50From: 2015-11-18Exp: 2025-11-18→ COMMON STOCK (11,400 underlying)
Footnotes (2)
- [F1]Shares acquired upon conversion of accrued salary at a conversion price of $0.22 per share.
- [F2]Series E-1 preferred stock is convertible into common stock pursuant to terms of certificate of designation filed by the issuer on December 3, 2020.
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001529012
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:00 PM ET
- Size
- 8.8 KB